Milestone Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Hi, everyone. Welcome and thank you for attending the virtual Needham Healthcare Conference. It's my pleasure to introduce Joe Oliveto, the President and CEO of Milestone Pharmaceuticals.
Thanks a lot, Mike, and really want to thank all the colleagues at Needham for the invitation and the opportunity to present today. And of course, thank all those in the audience who has taken the time out to hear the Milestone story.
I will be making forward-looking statements today. So, I'll direct you to our SEC filings for a full list of our disclosure statements.
So, let's start off with really the issue that Milestone is aiming to resolve here, and it is in these areas of certain types of tachycardias or arrhythmias, namely PSVT and atrial fibrillation with rapid ventricular rate. And, in both of these cases, patients with these conditions really experienced markedly symptomatic attacks, what we call attacks or events of high heart rates.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |